Gene: Cradd (CASP2 and RIPK1 domain containing adaptor with death domain) Rattus norvegicus
Analyze
Symbol: Cradd
Name: CASP2 and RIPK1 domain containing adaptor with death domain
Description: Predicted to have death domain binding activity, protease binding activity, and protein binding activity, bridging; predicted to be involved in several processes, including DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, apoptotic signaling pathway, and positive regulation of apoptotic process; predicted to localize to the cytoplasm and nucleus; orthologous to human CRADD (CASP2 and RIPK1 domain containing adaptor with death domain); INTERACTS WITH 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane; acrylamide; bisphenol A.
Type: protein-coding
RefSeq Status: PROVISIONAL
Also known as: death domain-containing protein CRADD; LOC314756; RAIDD
Orthologs:
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.0736,395,665 - 36,408,588 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.0736,457,911 - 36,470,834 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4732,504,279 - 32,517,581 (-)NCBIRGSC3.4rn4RGSC3.4
RGSC_v3.1732,379,423 - 32,536,642 (-)NCBI
Celera727,014,185 - 27,026,498 (-)NCBICelera
Cytogenetic Map7q13NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated

Genomics

Comparative Map Data
Position Markers
QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome
Promoters

Strain Variation

Strain Sequence Variants (Rnor 5.0)

Additional Information

External Database Links
Nomenclature History
 
More on Cradd
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

CRRD Object Information
CRRD ID: 1311010
Created: 2005-01-12
Species: Rattus norvegicus
Last Modified: 2019-04-23
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.